Catching the evader: Can monoclonal antibodies interfere with <italic>Staphylococcus aureus</italic> immune escape?

References

• Weidenmaier C, Goerke C, Wolz C. Staphylococcus aureus determinants for nasal colonization. Trends Microbiol 2012; 20:243-50; PMID:22494802; https://doi.org/10.1016/j.tim.2012.03.004
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32; PMID:9709046; https://doi.org/10.1056/NEJM199808203390806
   PubMed Web of Science ®Google Scholar
• Cameron DR, Howden BP, Peleg AY. The interface between antibiotic resistance and virulence in staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 2011; 53:576-82; PMID:21865195; https://doi.org/10.1093/cid/cir473
   PubMedGoogle Scholar
• Becattini S, Taur Y, Pamer EG. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol Med 2016; 22:458-78; PMID:27178527; https://doi.org/10.1016/j.molmed.2016.04.003
   PubMed Web of Science ®Google Scholar
• Venter H, Henningsen ML, Begg SL. Antimicrobial resistance in healthcare, agriculture and the environment: The biochemistry behind the headlines. Essays Biochem 2017; 61:1-10; PMID:28258225; https://doi.org/10.1042/EBC20160053
   PubMedGoogle Scholar
• Johnson RB. Human disease and the evolution of pathogen virulence. J Theor Biol 1986; 122:19-24; PMID:3796006; https://doi.org/10.1016/S0022-5193(86)80222-3
   PubMedGoogle Scholar
• Sharma A, Kumar Arya D, Dua M, Chhatwal GS, Johri AK. Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv 2012; 9:1325-32; PMID:22924701; https://doi.org/10.1517/17425247.2012.717927
   PubMed Web of Science ®Google Scholar
• Fedtke I, Götz F, Peschel A. Bacterial evasion of innate host defenses–the staphylococcus aureus lesson. Int J Med Microbiol 2004; 294:189-94; PMID:15493829; https://doi.org/10.1016/j.ijmm.2004.06.016
   PubMed Web of Science ®Google Scholar
• Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L, et al. A potential new pathway for staphylococcus aureus dissemination: The silent survival of s. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008; 3:e1409; PMID:18183290; https://doi.org/10.1371/journal.pone.0001409
   PubMed Web of Science ®Google Scholar
• McGuinness WA, Kobayashi SD, DeLeo FR. Evasion of neutrophil killing by staphylococcus aureus. Pathogens 2016; 5:E32; PMID:26999220; https://doi.org/10.3390/pathogens5010032
   PubMedGoogle Scholar
• O'Keeffe KM, Wilk MM, Leech JM, Murphy AG, Laabei M, Monk IR, Massey RC, Lindsay JA, Foster TJ, Geoghegan JA, et al. Manipulation of autophagy in phagocytes facilitates staphylococcus aureus bloodstream infection. Infect Immun 2015; 83:3445-57; PMID:26099586; https://doi.org/10.1128/IAI.00358-15
   PubMed Web of Science ®Google Scholar
• Garcia BL, Ramyar KX, Ricklin D, Lambris JD, Geisbrecht BV. Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of staphylococcal immune evasion proteins. Adv Exp Med Biol 2012; 946:113-33; PMID:21948365; https://doi.org/10.1007/978-1-4614-0106-3_7
   PubMedGoogle Scholar
• Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: A redundant arsenal of membrane-damaging virulence factors?. Front Cell Infect Microbiol 2012; 2:12; PMID:22919604; https://doi.org/10.3389/fcimb.2012.00012
   PubMed Web of Science ®Google Scholar
• Pier GB. Will there ever be a universal staphylococcus aureus vaccine?. Hum Vaccin Immunother 2013; 9:1865-76; PMID:23793522; https://doi.org/10.4161/hv.25182
   PubMed Web of Science ®Google Scholar
• Wertheim HFL, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JAJW, van Keulen PHJ, Vandenbroucke-Grauls CMJE, Meester MHM, Verbrugh HA. Risk and outcome of nosocomial staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364:703-5; PMID:15325835; https://doi.org/10.1016/S0140-6736(04)16897-9
   PubMed Web of Science ®Google Scholar
• Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson JK, Nguyen C, Chen WH, Roghmann MC. Lower antibody levels to staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 2012; 206:915-23; PMID:22807524; https://doi.org/10.1093/infdis/jis462
   PubMed Web of Science ®Google Scholar
• Otto M. Novel targeted immunotherapy approaches for staphylococcal infection. Expert Opin Biol Ther 2010; 10:1049-59; PMID:20528609; https://doi.org/10.1517/14712598.2010.495115
   PubMed Web of Science ®Google Scholar
• Diep BA, Le VTM, Badiou C, Le HN, Pinheiro MG, Duong AH, Wang X, Dip EC, Aguiar-Alves F, Basuino L, et al. IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Sci Transl Med 2016; 8:357ra124; PMID:27655850; https://doi.org/10.1126/scitranslmed.aag1153
   PubMedGoogle Scholar
• Hermos CR, Yoong P, Pier GB. High levels of antibody to panton-valentine leukocidin are not associated with resistance to staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis 2010; 51:1138-46; PMID:20946065; https://doi.org/10.1086/656742
   PubMed Web of Science ®Google Scholar
• Yoong P, Pier GB. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci USA 2010; 107:2241-6; PMID:20133867; https://doi.org/10.1073/pnas.0910344107
   PubMed Web of Science ®Google Scholar
• Yoong P. Enhancement of bacterial virulence by antibody neutralization of immune-activating toxins. Virulence 2010; 1:409-13; PMID:21178480; https://doi.org/10.4161/viru.1.5.12705
   PubMed Web of Science ®Google Scholar
• Laabei M, Uhlemann AC, Lowy FD, Austin ED, Yokoyama M, Ouadi K, Feil E, Thorpe HA, Williams B, Perkins M, et al. Evolutionary trade-offs underlie the multi-faceted virulence of staphylococcus aureus. PLoS Biol 2015; 13:e1002229; PMID:26331877; https://doi.org/10.1371/journal.pbio.1002229
   PubMed Web of Science ®Google Scholar
• Becker REN, Berube BJ, Sampedro GR, DeDent AC, Bubeck Wardenburg J. Tissue-specific patterning of host innate immune responses by staphylococcus aureus α-toxin. J Innate Immun 2014; 6:619-31; PMID:24820433; https://doi.org/10.1159/000360006
   PubMedGoogle Scholar
• Kim HK, Cheng AG, Kim H-Y, Missiakas DM, Schneewind O. Nontoxigenic protein a vaccine for methicillin-resistant staphylococcus aureus infections in mice. J Exp Med 2010; 207:1863-70; PMID:20713595; https://doi.org/10.1084/jem.20092514
   PubMed Web of Science ®Google Scholar
• Kim HK, Emolo C, DeDent AC, Falugi F, Missiakas DM, Schneewind O. Protein A-specific monoclonal antibodies and prevention of staphylococcus aureus disease in mice. Infect Immun 2012; 80:3460-70; PMID:22825452; https://doi.org/10.1128/IAI.00230-12
   PubMed Web of Science ®Google Scholar
• Thomer L, Emolo C, Thammavongsa V, Kim HK, McAdow ME, Yu W, Kieffer M, Schneewind O, Missiakas D. Antibodies against a secreted product of staphylococcus aureus trigger phagocytic killing. J Exp Med 2016; 213:293-301; PMID:26880578; https://doi.org/10.1084/jem.20150074
   PubMedGoogle Scholar
• Hoekstra H, Romero Pastrana F, Bonarius HPJ, van Kessel KPM, Elsinga GS, Kooi N, Groen H, van Dijl JM, Buist G. A human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCIN. Virulence 2017. Advance online publication. PMID:28277903; https://doi.org/10.1080/21505594.2017.1294297
   PubMedGoogle Scholar